Revenue by Segment

Financials in millions CAD. Fiscal year is September - August.

Millions CAD. Fiscal year is Sep - Aug.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug '24 Aug 31, 2024	Aug '23 Aug 31, 2023	Aug '22 Aug 31, 2022	Aug '21 Aug 31, 2021	Aug '20 Aug 31, 2020
Biopharmaceutical Development of New Medicines	136.21K	-
Total	136.21K	-

Revenue by Geography

Financials in millions CAD. Fiscal year is September - August.

Millions CAD. Fiscal year is Sep - Aug.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Aug '24 Aug 31, 2024	Aug '23 Aug 31, 2023	Aug '22 Aug 31, 2022	Aug '21 Aug 31, 2021	Aug '20 Aug 31, 2020	Aug '19 Aug 31, 2019	Aug '18 Aug 31, 2018
Canada	136.21K	840.53K				773.79K	567.43K
Canada Growth	-83.80%	-				36.37%	-
Total	136.21K	840.53K				773.79K	567.43K
Total Growth	-83.80%	-				36.37%	-

Source: S&P Global Market Intelligence.